Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
The Urgent Need for Reliable Cell Models in ALS Research
Ncardia @ AD/PD 2024: The Latest In Alzheimer’s & Parkinson’s Research
Ncardia's Remarkable Journey in 2023
.png)
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
